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ALTHOUGH there is a voluminous amount of literature on salivary gland
tumours, investigations based on significantly large number of cases have been
relatively few. From this part of the world, reliable information is even less
readily obtainable. Inthe present series, 670 salivarygland tumours are available
for study. It is hoped that this large material may furnish additional data on
these tumours and on those aspects which are peculiar to Malaya in particular.
MATERIALS AND METHODS
This study is based on the material collected in the Pathology Division of the
Institute for Medical Research, Kuala Lumpur, over the eighteen year period from
1948-1965 inclusive. The material comprised 670 cases of salivary gland
tumours.
All histological sections were re-examined. Only the brief clinical histories
which accompanied the specimens were available. These were studied in relation
to the different histological types.
RESULTS
Frequency
The State of Selangor, which contains the capital of Malaya, has the best
records and medical facilities. The standardised rate for salivary gland tumours
computed in this state is therefore taken as a representative example.
In the year 1965, the end-of-year population figure is given as 694,064 males
and 645,078 females in Selangor. During this year, 14 new cases of salivary
gland tumours were seen, 9 ofwhich were in males and 5 in females. This gives an
incidence rate as follows:
Males: 1-3 per 100,000 population per year.
Females: 0-8 per 100,000 population per year.
Racial Diistribution
The population of Malaya is made up of three main racial groups: Malays,
Chinese and Indians. The percentage of salivary gland tumours relative to the
total number oftumours in these three races is shown in Fig. 1.
Histology
The classification adopted is that of Foote and Frazell (1954). Table I shows
the different histological varieties and their sites of origin.
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FiG. 1. The percentage of salivary gland tumours relative to the total number of tumours
in Malavs, Chinese and Indians.
TABLE I-Histological Types ofSalivary Gland Tumours and their
Sites of Origin
Sites
Tumour type
Benign mixed tumoui
Malignant mixed tumour
Adenoid cystic carcinoma
Adenocarcinoma a
Papillary cystadenoma
lymphomatosum
Mucoepidermoid carcinoma
Squamous carcinoma
Haemangioma
Oncocytoma
Adenoma
Neurofibroma
Lymphosarcoma
Metastatic melanoma
Undifferentiated malignant
tumours
Total
% of total
Parotid1
271
24
9
37
28
28
13
20
2
8
0
1
Subman-
dibular
77
4
0
5
5
5
4
0
1
0
2
2
0
Palate
18
6
0
0
0
Minor
17
1
10
9
1
1
0
0
1
0
0
Unspeci-
fied
46
9
4
10
5
4
1
0
1
1
0
0
Total
375
43
29
66
43
40
21
23
3
12
2
1
O/ of
total
56
6-4
4.3
9'-8
6-4
6-0
3 - 1
3.4
0 4.5
0-775
1 *8
0 3
0 15
A 1 0 0 2 7 1-0
393 101 37 42 97 670
58- 70 15- 1% 5-sa% 6-3o 14-5%
A further subdivision of the figures shows that there is a higher frequency of
malignant tumours arising from the palate and minor salivary glands than in the
parotid and submandibular glands (Table II).
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TABLE II-Proportion ofBenign and Malignant Salivary Gland Tumours
in the Different Sites
Tumour type
Benign tumours
Malignant tumours
Total
Submani-
Parotid bular
277 80
(71%) (79%)
166 21
(29%) (21%)
393 101
The histological descriptions of the different types of tumours are well
documented; it is, therefore, unnecessary to repeat them here. However, in the
re-examination ofthe slides in the present series, one interesting case is seen which
merits further comment. This is a malignant oncocytoma removed from the left
parotid gland of a 70-year-old Chinese man. Histologically all stages oftransition
from a benign tumour to a frankly malignant one can be traced. In most parts
the tumour shows the typical appearance of an oncocytoma, with cells ofuniform
size containing pink granular cytoplasm and a distinct vesicular nucleus (Fig. 2).
Scattered among these cells, however, are small groups of cells which have a more
bizarre appearance. The nuclei are very large and are irregular in shape and size.
Abnormal mitotic figures can be seen (Fig. 3 and 4). In some parts large portions
of the tumour are found to be replaced by these atypical cells (Fig. 5). In yet
other areas the tumour has become frankly malignant, consisting of cells so
undifferentiated and pleomorphic that all resemblance to salivary gland tissue is,
lost (Fig. 6). There is infiltration ofthe underlying bone (Fig. 7).
Sex Distribution
This is shown in Table III for the different histological types.
TABLE III.-Sex Distribution for the Different Histological Types of
Salivary Gland Tumours
Tumour type
Benign mixed tumour
Malignant mixed tumour .
Adenoid cystic carcinoma
Adenocarcinoma
Papillary cystadenoma lymphomatosum
Mucoepidermoid carcinoma
Squamous carcinoma
Haemangioma
Total
Male
Number Per cent
192 51
26 60-5
15 51*7
35 53
36 83.7
23 57.5
14 66 7
9 39
350 54 8
Female
A
Number Per cent
182 49
17 39.5
14 48.3
31 47
7 16.3
17 42-5
7 33.3
14 61
289 45 2
Age Distribution
Since many of the salivary gland tumours are extremely slow growing, the age
of onset of the tumour, rather than the age when the patient first presents, will
give a more representative picture ofthe age distribution. The results are shown
by the histogram in Fig. 8.
Palate
20
(54%)
17
(46%)
37
Minor
21
(50%)
21
(50%)
42
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Duration ofTumours
The time interval between the onset of the tumour and when the patient first
presents for treatment is given in Table IV.
TABLE IV.-Relation of Duration of Tumour to Histological Type
Duration in years
<1 1-5 5-10 >10
Benign mixed tumour 67 159 31 28
Malignant mixed tumour . . . 13 7 3 2
Adenoid cystic carcinoma 5 12 1 1
Adenocarcinoma . . . . 23 17 2 1
Papillary cystadenoma lymphomatosum . 13 16 2 2
Mucoepidermoid carcinoma . . . 9 12 5 0
Squamous carcinoma . . 10 4 0 2
Clinical Aspects
The invasive qualities of salivary gland tumours are usually manifested by
ulceration of the overlying skin or mucous membrane, involvement of the facial
nerve and bone, attachment to surrounding subcutaneous tissues, and metastases
to the adjacent lymph nodes. The frequency with which these structures are
involved by the different histological varieties of salivary gland tumours is given
inTableV. Nofollow-up histories are available and none ofthe cases areexamined
TABLE V.-The Frequency ofInvolvement of VarioUs Tissues by the Different
Histological Types ofSalivary Gland Tumours
Frequency of involvement
Tumour type
Benign mixed tumour
Malignant mixed tumour.
Adenoid cystic carcinoma
Adenocarcinoma
Papillary cystadenoma lymphomatosum
Mucoepidermoid carcinoma
Squamous carcinoma
Haemangioma
Oncocytoma
Adenoma
Neurofibroma
Lymphosarcoma
Metastatic melanoma
Undifferentiated malignant tumour
'Total
Skin or
mucous
membrane
1
6
4
11
0
0
3
1
0
0
0
0
0
0
26
Facial
nerve
2
7
1
6
0
1
2
0
1
0
0
0
0
0
Surround-
ing
tissue
2
2
1
5
0
3
3
2
1
0
1
0
1
2
Bone
0
4
0
4
0
0
1
0
1
0
0
0
0
0
Cervical
lymph
node
0
3
0
11
0
2
4
0
0
0
0
0
0
0
20 23 10 20
EXPLANATION OF PLATES
FIG. 2.-Typical appearance of an oncocytoma. H. & E. x350.
FIG. 3.-Occasional large, bizarre looking cells. H. & E. X520.
FIG. 4.-Large cell with abnormal mitotic figure. H. & E. x 520.
FIG. 5.-Large areas ofthe oncocytoma replaced by abnormal looking cells. H. & E. x 350.
FIG. 6.-Frankly malignant area showing no resemblance to salivary gland tissue. H. & E.
x350.
FIG. 7.-Tumour invading bone. H. & E. x 350.
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TUMOUR
TYPE NQ
BENIGN 60
MIXED TUMOUR 40
MALIGNANT 6_
MIXED TUMOUR 2
ADENOID CYSTIC 6
CARCINOMA 4
2
ADENOCARCINOMA 6
2
14
PAPILLARY 12
LYMPHOMATOSUM 4
2-
MUCOEPIDERMOID 6
CARCINOMA 2
SQUAMOUS 4
CARCINOMA 2-
10
8
HAEMANGIOMA 6
4
0-10 11-20 21-30 31-40 41-50 51-60 61-70 71-80 81-90
AGE GROUPS
FIG. 8.-Age of onset for the different histological types of salivary gland tu.mours, shown
as numbers of cases in each decade.
post-mortem so it is not possible to comment on the frequency of metastases to
other organs, but at the time of presentation no clinical evidence of distant
metastases has been observed in any ofthe cases.
DISCUSSION
It has often been said that salivary gland tumours are unduly common in the
poor, tropical areas of the world. Davies, Dodge and Burkitt (1964), however,
found no evidence to support this popular belief. Their standardised rates for
Africans in the district of Kyadondo were no higher when compared with figures
for the United States and Norway. The present findings in Malaya of 13 and
0*8 per 100,000 population per year for males and females respectively are compar-
able to those quoted by Davies et al., except that the male: female ratio appears
to be reversed.
When the frequency of salivary gland tumours is viewed in relation to the
total number of tumours, the figure of 4.1% obtained for the Malays is relatively
high compared with the 2-3% for the Chinese and 1.7% for the Indians (Fig. 1).
In European races, salivary gland tumours comprise less than 3% of all tumours
(Eneroth, 1964). The Malay preponderance is difficult to explain but Marsden
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(1951) thought it might be related to malnutrition. This is indeed a possibility
for Thomson (1960), in a survey ofthe Malay rural communities in Malaya, found
the inhabitants to be in a low level ofnutritional health.
There seems to be some variation in the pattern of site distribution of salivary
gland tumours in different countries. Marsden, who investigated the problem in
Malaya in 1951 statedthat 30% ofthe salivaryglandtumours in his series involved
the submandibular gland. This is a very high figure indeed when compared with
13.7% for Sheffield, 16.6% for South Africa and 19-4% for Uganda, all quoted
by Davies et al., and the 12% reported by Cooray et al. (1950) from Ceylon. The
present series, however, do not confirm Marsden's findings. In Table I, it can be
seenthat the submandibulargland is involved inonly 15-1% ofthe cases. Another
notable difference is that the site oforigin in 14.5% ofthe cases has been classified
as " unspecified " in the present series, whereas Marsden had none. Under the
" unspecified " category are grouped all those cases which are stated to have
arisen from poorly defined anatomical areas like " face ", " jaw " or " neck ".
Although it is possible that a few of these cases may have originated from the
submandibular gland, it seems more likely that the majority of them have arisen
from the parotid, this gland being bigger and more irregular in shape.
The frequency of palatal involvement is low in Malaya (5.5%) compared with
Uganda (19.4%) and South Africa (12.9%). An interesting finding is that nearly
half (46%) the tumours which arose from the palatal glands are malignant whereas
only 29% of parotid, and 21% of submandibular tumours are of this nature
(Table II). This is in agreement with Fine, Marshall and Horn (1960) who
stated that " recent statistics indicate a greater incidence of malignant tumours
among the minor as contrasted to the major salivary glands." The frequency of
malignant parotid tumours also follow the same general pattern as other series.
Patey, Thackray and Keeling (1965) reviewed some of the larger series published
since 1950 and found that the figures quoted for the frequency of malignant
parotid tumours ranged from 15% to 31%.
When the different histological types oftumours are considered separately, the
benign mixed variety is found to occur with the highest frequency, forming just
over half the total number (56%). This is in fair agreement with the results of
Foote and Frazell (1953) and Grage, Lober and Shahon (1961) but not as high as
some reported series (Bauer and Bauer, 1953; Kirklin et al., 1951). The present
investigation, therefore, does not lend support to Marsden's conclusions that mixed
salivary gland tumours "show an unduly high incidence in Malaya ". It is
possible that, in past investigations, other histological types were mistakenly
classified under the heading of mixed tumours, for as Eneroth (1964) found, only
569 of618 tumours originally diagnosed as mixed tumours proved to be true mixed
tumours on histological re-examination.
The malignant transformation of mixed tumours has always created much
interest. Following Foote and Frazell, the tumours placed in the category of
" malignant mixed tumours " in the present series are those in which, along with
features of ordinary mixed tumours, there are areas known to be associated with
a tendency to metastasise (such as marked cellularity, pleomorphism and frequent
mitoses). Using these criteria, there are 43 malignant mixed tumours and 375
benign mixed tumours in the present series. This compares well with the 57
malignant mixed tumours and 494 benign mixed tumours of Frazell's (1954)
material. From Table V, it can be seen that, when compared with the benign
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mixed tumours, the malignant mixed tumours show a definitely more sinister
clinical behaviour, with frequent involvement of surrounding tissues, facial nerve
and bone, and metastases to the regional lymph nodes.
A question often asked is whether a malignant mixed tumour is malignant
from the outset or it represents a malignant alteration from a benign variety.
Foote and Frazell favour the latter hypothesis their beliefbeing based on the fact
that the average age ofthe patients with malignant mixed tumours was about 10
years greater than the average of those with the benign varieties. Beahrs et al.
(1957) were ofthe same opinion. From Fig. 2 it can be seen that the age ofonset
for the malignant mixed tumours in the present series shows two peaks. One
corresponds to 50 years which is about 10-20 years greater than the average for
benign mixed tumours. On the other hand, there are those which occur below the
age of20. It would appear from this that, although many ofthe malignant mixed
tumours have arisen from a preceding long standing benign mixed tumour, some
ofthem may, in fact, have been malignant from the outset. Supportive evidence
for this is found in Table IV where it can be seen that in over half the cases of
malignant mixed tumours, the duration between the onset ofthe tumour and when
the patient first presents for treatment is less than a year. This is in direct
contrast to the benign mixed tumours where a large number are present for 5
years and even longer.
The findings for the group of adenoid cystic carcinoma in the present series are
comparable to those reported by investigators like Moran et al. (1961), and Wawro
and McAdams (1954). These tumours constitute 4.3% of all salivary gland
tumours and are most commonly found in the palatal and minor salivary glands
than in the parotid (Table I). No significant sex predilection is apparent (Table
III) and the tumours occur most frequently in the fourth and fifth decades
(Fig. 2). They are usually slow growing tumours (Table IV) with occasional
manifestations of malignancy in their clinical behaviour (Table V). However,
no case of metastases is found in the present material.
The group of adenocarcinoma consists of all those tumours which, histo-
logically, are seen to be frankly malignant and to exhibit some tubular formation.
No attempthas beenmadeto dividetheminto different sub-types. Thesetumours
make up 9.8% of the total salivary gland tumours and arise mainly from the
parotid gland. There is a slight male preponderance and the usual age ofonset is
between the fourth and sixth decades. When compared with the adenoid cystic
carcinomas, the adenocarcinomas are much more malignant in their clinical
behaviour. From Table IV, it can be seen that the majority of adenocarcinomas
are fast growing and they have the highest frequency of cervical lymph node
involvement among all the salivary gland tumours (Table V).
In the present material, the designation of " mucoepidermoid carcinoma
is applied to all those tumours which histologically are seen to consist ofa mixture
of mucus-secreting glandular cells and epidermoid cells. No attempt has been
made to subdivide them histologically into different grades of malignancy. This
type of tumour is found to make up 6% of all salivary gland tumours with the
parotid glandbeing themost common site oforigin. Intheliterature, therecorded
frequency ranges from about 3% of Woolner, Petter and Kirklin (1954) and
Gray, Hendrix and French (1963) to 9% of Foote and Frazell. Whereas the
highest incidence of this tumour has been believed to occur in the fourth and
fifth decades by some authors, an interesting feature of the present series is the
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relatively young age distribution (Fig. 2). This is in agreement with Bhaskar
and Bernier (1962) who found the highest incidence between the second and third
decades and with Bauer and Bauer (1953) whose patients were all less than 35
years of age.
There are marked discrepencies in the reported frequency of squamous
carcinoma in the literature. For example, Rosenfeld et al. (1966) gave a figure of
11% whereas Eneroth (1964) only managed to find 1 case out of 802 patients.
This may be due, in fact, to the difficulty in separating these tumours from some
of the high grade mucoepidermoid neoplasms. In the present series squamous
carcinomas make up 3*1% of all salivary gland tumours. They occur at an older
age group than the mucoepidermoid tumours (Fig. 2) and there is a male preponder-
ance of 2: 1 (Table III). The clinical behaviour of the squamous carcinoma
appears to be more sinister than the mucoepidermoid variety (Table V). This is
in agreement with the findings ofPatey et al. (1965) who showed that the squamous
carcinomas in their series had an extremely poor prognosis.
The group of tumours known as papillary cystadenoma lymphomatosum or
adenolymphoma comprised 6-4% of the total in the present material. Other
large series like Foote and Frazell's and Eneroth's (1964) quoted a frequency of
just over 5%. It is interesting to note that Davies et al. (1964) did not find a
single case among 129 salivary gland tumours in Uganda. The present findings
confirm the marked male preponderance, the relatively old age of onset and the
benign nature ofthese tumours. Many theories have been put forward to explain
the histogenesis of these tumours but there- now seems to be general agreement
that they are in fact adenomata of heterotropic salivary tissue in regional parotid
lymph nodes. The frequency of bilateral occurence has been cited as supportive
evidence for the theory of lymph node origin of these tumours. Shaw and
Friedmann (1959) reported two cases and Foote and Frazell found six out of
their 44 patients had bilateral involvement. On the other hand, Eneroth (1964)
did not find any case of bilateral papillary cystadenoma lymphomatosum and
neither did Hevenor and Clark (1950) in their material. In the present series,
two cases out of 43 shows bilateral involvement.
The occasional finding of tuberculous lesions associated with the lymphoid
tissue of these tumours are considered as further evidence for their lymph node
origin. Cases were reported by Owen (1946), Hevenor and Clark (1950) and Shaw
and Friedmann (1959), but only Collins and Shucksmith (1953) could demonstrate
tubercle bacilli in their material. Since these appear to be the only documented
cases in the literature it would be of interest to record another case found in the
present series. This is in a Chinese male of 51 years of age who complained of a
mass below the left ear for about a month. Five days before his attendance at
hospital, there was a sudden increase in size. The clinical diagnosis was enlarge-
ment of a cervical lymph node but at operation the lump was found to be arising
from the lower pole of the parotid gland. Histological examination shows the
structure of a papillary cystadenoma lymphomatosum with scattered areas of
caseating tuberculous lesions in the lymphoid stroma. No tubercle bacilli can be
seen. There is no clinical evidence of any tuberculosis elsewhere in the body.
Another interesting feature of the present series is the seven cases of papillary
cystadenoma lymphomatosum found in the submandibular and minor salivary
glands compared with 28 in the parotid. Since only the parotid gland develops in
close association with aggregates of lymphoid tissue (Thompson and Bryant,
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1950), the finding of extra-parotid adenolymphomata is difficult to explain by the
present theory.
The oncocytoma is an extremely rare tumour as is evidenced by the report of
only one case in 877 tumours of major salivary glands (Foote and Frazell, 1953)
and 4 cases in 802 tumours of the parotid gland (Eneroth, 1964). In the present
-series there are three cases out of a total of 670 salivary gland tumours. An
interesting feature is the malignant transformation in one ofthe cases (Fig. 2 to 7).
Although most of the oncocytomata reported in the literature are stated to be
benign, occasional cases have been recorded where a malignant change had
supervened (Bauer and Bauer, 1953; Eneroth, 1965).
The group ofhaemangiomas deserve a briefmention. Nearly all ofthem occur
in infancy and early childhood and are in fact the most common type of salivary
gland tumour found in children. Kauffman and Stout (1963) observed a similar
pattern. Histologicaliy, those haemangiomas found in early life are very cellular
haemangioendothieliomas whereas the occasional cases found in young adults are
of the cavernous variety.
SUMMARY
1. A study has been made of 670 salivary gland tumours in Malaya.
2. Data regarding incidence, racial distribution, sites of origin, sex ratio, age
ofonset, duration ofgrowth, frequency ofmalignant change, and clinical behaviour
for the different histological varieties are analysed.
3. The results obtained are discussed in relation to those ofother investigators.
I would like to thank The Director, Institute for Medical Research for
permission to use the pathology material, the Department of Medical Illustration
forthephotographs, andMissJenny Chayfortyping the tables andthemanuscript.
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